Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.89 USD
Change Today +0.13 / 4.71%
Volume 2.0M
OREX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Stuttgart
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Heather D. Turner J.D.

AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

42$1,605,609
As of Fiscal Year 2014

Background*

Ms. Heather D. Turner, J.D., served as Secretary and General Counsel of Orexigen Therapeutics, Inc. from June 2007 to June 2015 and as its Senior Vice President from May 2010 to June 2015. Ms. Turner served as Vice President of Orexigen Therapeutics, Inc. She has an extensive experience involving public reporting, compliance and disclosure issues, as well as broad knowledge and experience in negotiating and structuring commercial relationships including distribution, ...

Read Full Background

Corporate Headquarters*

3344 North Torrey Pines Court
La Jolla, California 92037

United States

Phone: 858-875-8600
Fax: 858-875-8650

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

JD
University of California-Los Angeles School of Law
BA
University of California, Santa Barbara

Other Affiliations*

Annual Compensation*

Salary$379,250
Total Annual Compensation$379,250

Stock Options*

All Other Compensation$7,920
Exercised Options354,031
Exercised Options Value$1,071,973
Exercisable Options905,390
Unexercisable Options546,542
Total Value of Options$1,071,973
Total Number of Options1,805,963

Total Compensation*

Total Annual Cash Compensation$565,418
Total Short Term Compensation$379,250
Other Long Term Compensation$7,920
Total Calculated Compensation$1,605,609
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OREX:US $2.89 USD +0.13

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jack Lief Ph.D.Co-Founder, Chairman, Chief Executive Officer, President and Principal Financial Officer
Arena Pharmaceuticals, Inc.
$746.8K
Seth H. Z. Fischer Chief Executive Officer, Chief Commercial Officer and Director
VIVUS Inc.
$650.0K
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.0M GBP
Lars Rebien Sørensen Chief Executive Officer, President and Member of Executive Management
Novo Nordisk A/S
kr15.2M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OREXIGEN THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.